Ken Griffin West Pharmaceutical Services Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 48,200 shares of WST stock, worth $15.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,200

Previous 47,000 2.55%

Holding current value

$15.8 Million

Previous $15.5 Million 6.55%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$277.16 - $333.3 $64.4 Million - $77.4 Million	-232,218 Reduced 82.83%	48,126 $14.4 Million
Q2 2024 Aug 14, 2024	SELL	$314.68 - $395.94 $245 Million - $309 Million	-779,802 Reduced 73.56%	280,344 $92.3 Million
Q1 2024 May 15, 2024	BUY	$338.27 - $413.0 $44.4 Million - $54.2 Million	131,129 Added 14.11%	1,060,146 $420 Million
Q4 2023 Feb 14, 2024	SELL	$318.29 - $392.21 $198 Million - $244 Million	-622,761 Reduced 40.13%	929,017 $327 Million
Q3 2023 Nov 14, 2023	BUY	$354.9 - $412.41 $177 Million - $206 Million	498,447 Added 47.32%	1,551,778 $582 Million
Q2 2023 Aug 14, 2023	SELL	$334.63 - $382.47 $15.3 Million - $17.5 Million	-45,851 Reduced 4.17%	1,053,331 $403 Million
Q1 2023 May 15, 2023	BUY	$232.5 - $346.47 $218 Million - $325 Million	938,098 Added 582.37%	1,099,182 $381 Million
Q4 2022 Feb 14, 2023	SELL	$209.34 - $261.61 $11.7 Million - $14.6 Million	-55,815 Reduced 25.73%	161,084 $37.9 Million
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $20.2 Million - $28.2 Million	81,966 Added 60.75%	216,899 $53.4 Million
Q2 2022 Aug 15, 2022	SELL	$280.61 - $420.45 $73 Million - $109 Million	-260,198 Reduced 65.85%	134,933 $40.8 Million
Q1 2022 May 16, 2022	BUY	$357.49 - $445.92 $141 Million - $176 Million	394,115 Added 38790.85%	395,131 $162 Million
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $22.1 Million - $25.9 Million	-54,943 Reduced 98.18%	1,016 $476,000
Q3 2021 Nov 15, 2021	BUY	$363.01 - $468.47 $10.3 Million - $13.2 Million	28,271 Added 102.11%	55,959 $23.8 Million
Q2 2021 Aug 16, 2021	BUY	$284.77 - $363.2 $3.13 Million - $3.99 Million	10,977 Added 65.69%	27,688 $9.94 Million
Q4 2020 Feb 16, 2021	BUY	$261.16 - $301.66 $3.01 Million - $3.48 Million	11,541 Added 223.23%	16,711 $4.73 Million
Q3 2020 Nov 16, 2020	SELL	$224.99 - $288.02 $30.6 Million - $39.1 Million	-135,855 Reduced 96.33%	5,170 $1.42 Million
Q2 2020 Aug 14, 2020	BUY	$149.8 - $227.17 $19.3 Million - $29.3 Million	128,809 Added 1054.43%	141,025 $32 Million
Q1 2020 May 15, 2020	SELL	$128.96 - $174.76 $2.97 Million - $4.03 Million	-23,052 Reduced 65.36%	12,216 $1.86 Million
Q4 2019 Feb 14, 2020	SELL	$137.6 - $151.21 $12.8 Million - $14.1 Million	-93,193 Reduced 72.55%	35,268 $5.3 Million
Q3 2019 Nov 14, 2019	BUY	$121.41 - $150.02 $8.09 Million - $10 Million	66,639 Added 107.79%	128,461 $18.2 Million
Q2 2019 Aug 14, 2019	BUY	$111.27 - $125.15 $5.45 Million - $6.14 Million	49,024 Added 383.06%	61,822 $7.74 Million
Q1 2019 May 15, 2019	BUY	$94.53 - $110.2 $897,373 - $1.05 Million	9,493 Added 287.23%	12,798 $0
Q4 2018 Feb 14, 2019	BUY	$93.0 - $123.98 $45,291 - $60,378	487 Added 17.28%	3,305 $323,000
Q3 2018 Nov 13, 2018	SELL	$98.01 - $123.47 $55,669 - $70,130	-568 Reduced 16.77%	2,818 $0
Q2 2018 Aug 10, 2018	SELL	$83.32 - $101.88 $2.82 Million - $3.44 Million	-33,803 Reduced 90.9%	3,386 $0
Q1 2018 May 11, 2018	BUY	$85.56 - $102.4 $384,335 - $459,980	4,492 Added 13.74%	37,189 $3.28 Million
Q4 2017 Feb 09, 2018	BUY	$91.65 - $101.65 $2.57 Million - $2.85 Million	28,054 Added 604.22%	32,697 $3.23 Million
Q3 2017 Nov 09, 2017	BUY	$84.54 - $96.75 $392,519 - $449,210	4,643	4,643 $447,000

Others Institutions Holding WST

# of Institutions

802

Shares Held

64.3M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.3B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account